NCT05767346Phase 3Completed

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM

Study sponsor: Cytokinetics

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-02-28Actual
Enrollment · participants175Actual
Source updated2026-06-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Change in peak oxygen uptake (pVO2) by cardiopulmonary exercise testing (CPET). After: Measure: Change in Peak Oxygen Uptake (pVO2) by Cardiopulmonary Exercise Testing (CPET).

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview